Global CAR T-Cell therapy Market is Expected to Reach $6.1 Billion by 2031

CAR T-Cell
therapy Marke

Global CAR T-Cell therapy Market is
Expected to Reach $6.1 Billion by 2031:
Allied Market Research
According to a new report published by Allied Market Research,
titled, “CAR T-Cell therapy Market," The car t-cell therapy market
was valued at $1.7 billion in 2021, & is estimated to reach $6.1 billion
by 2031, growing at a CAGR of 13.5% from 2022 to 2031. Chimeric
antigen receptor (CAR) T-cell therapy treats certain cancer by turning
T-cells into more efficient cancer-fighting cells. CAR T-cell therapy is a
novel targeted approach, which involves genetic engineering of T-
cells to specifically target the receptors on cancer cells.
Key Findings Of The Study –
• By drug type, the axicabtagene ciloleucel segment held the largest
share in the CAR T-cell therapy market in 2021.
• By indication, the lymphoma segment held the largest share in the
CAR T-cell therapy market in 2021.
• By end user, the cancer centers segment is expected to show the
fastest market growth during the forecast period.

Covid-19 Scenario:
• The COVID-19 outbreak is anticipated to have a
negative impact on the market, as huge number
of medical college and hospitals across the
globe were restructured to increase the hospital
capacity for patients diagnosed with COVID-19.
• The significant reduction in clinical trials due to
strict government guidelines against COVID-19,
resists the growth of CAR T-cell therapy market
size.
Download Free Sample Report at:
https://www.alliedmarketresearch.com/requestsample/17358

List of Key Players Profiled in The Report:
• Autolus Therapeutics,
• Bluebird bio, Inc.,
• Bristol-Myers Squibb,
• Caribou Biosciences, Inc.,
• Cartesian Therapeutics, Inc.,
• Celgene Corporation,
• Cellectis, Celyad Oncology,
• Gilead Sciences, Inc. (Kite Pharma Inc.),
• Intellia Therapeutics,
• Juno Therapeutics, Inc.,
• Merck & Co., Inc.,
• Miltenyi Biotech,
• Novartis AG,
• Pfizer, Inc.,
• Sorrento Therapeutics, Inc.

ABOUT US
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP
based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses
with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view
to provide business insights and consulting to assist its clients to make strategic business decisions and achieve
sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps
us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market
Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to
maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in
the reports published by us is extracted through primary interviews with top officials from leading companies of domain
concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with
knowledgeable professionals and analysts in the industry.
Contact:
David Correa
5933 NE Win Sivers Drive#205, Portland, OR 97220 United States, USA/Canada
(Toll Free): +1-800-792-5285, +1-503-894-6022, +1-503-446-1141, UK: +44-845-528-1300, Hong Kong: +852-301-84916, India
(Pune)
help@alliedmarketresearch.com
Follow Us on LinkedIn: https://www.linkedin.com/company/allied-market-research

THANK YOU